48
Participants
Start Date
August 22, 2019
Primary Completion Date
April 2, 2020
Study Completion Date
April 2, 2020
Glucagon RTU Injection With Insulin Pump Reduction
0.15 mg injection with 50% pump reduction
Vehicle for Glucagon RTU Injection With Insulin Pump Reduction
vehicle injection with 50% pump reduction
Glugaon RTU Injection Without Insulin Pump Reduction
0.15 mg injection without pump reduction
LMC Clinical Research Inc, Toronto
Lead Sponsor
Xeris Pharmaceuticals
INDUSTRY